Kasten Inc
Kasten, Inc., doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings. It principally focuses on delivering solutions to those people who are affected by antimicrobial resistance and who need phar… Read more
Kasten Inc (KAST) - Total Liabilities
Latest total liabilities as of December 2024: $564.88K USD
Based on the latest financial reports, Kasten Inc (KAST) has total liabilities worth $564.88K USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Kasten Inc - Total Liabilities Trend (2013–2024)
This chart illustrates how Kasten Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Kasten Inc Competitors by Total Liabilities
The table below lists competitors of Kasten Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NexTech FAS Technologies Inc
PINK:NXSL
|
USA | $4.22 Million |
|
NFT Technologies Inc
PINK:NFTFF
|
USA | $977.57K |
|
Stemsation International Inc
PINK:STSN
|
USA | $1.60 Million |
|
Bit Brother Limited
PINK:BETSF
|
USA | $3.37 Million |
|
Enteq Upstream
LSE:NTQ
|
UK | GBX1.26 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Kasten Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kasten Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kasten Inc (2013–2024)
The table below shows the annual total liabilities of Kasten Inc from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $564.88K | -0.85% |
| 2023-12-31 | $569.72K | +3016.64% |
| 2022-12-31 | $18.28K | -30.84% |
| 2021-12-31 | $26.43K | -8.88% |
| 2017-12-31 | $29.01K | -1.33% |
| 2016-12-31 | $29.40K | -6.25% |
| 2015-12-31 | $31.36K | +83.82% |
| 2014-12-31 | $17.06K | 0.00% |
| 2013-12-31 | $17.06K | -- |